News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

enGene, Inc. Announces Changes to the Board of Directors



2/8/2008 9:33:10 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - February 07, 2008) - enGene Inc., a privately held biotechnology company developing an innovative approach for the treatment of diabetes called GEMS™-Insulin, announced today that the board welcomed new member A. Sinclair Dunlop and announced the retirement of John C. Brown and A. Lad Burgin from the board following their significant contribution to enGene.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES